Evidence map›Paper›PMID 32019237›Full record

ArticleInternational journal of molecular sciences2020

Oral Intake of EPA:DHA 6:1 by Middle-Aged Rats for One Week Improves Age-Related Endothelial Dysfunction in Both the Femoral Artery and Vein: Role of Cyclooxygenases.

Sébastien Gaertner, Cyril Auger, Muhammad A Farooq, Brigitte Pollet, Sonia Khemais-Benkhiat, Zahid R Niazi, Sophie Schrevens, Sin-Hee Park, Florence Toti, Dominique Stephan and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sébastien GaertnerINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.
Cyril AugerINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.ORCID 0000-0003-0695-3841
Muhammad A FarooqINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.
Brigitte PolletUMR 7021, Laboratoire Bioimagerie et Pathologies, Faculté de Pharmacie, 67401 Illkirch, France.
Sonia Khemais-BenkhiatINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.
Zahid R NiaziINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.
Sophie SchrevensINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.
Sin-Hee ParkINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.ORCID 0000-0002-7452-9615
Florence TotiINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.
Dominique StephanINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.
Valérie B Schini-KerthINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerativ.e Nanomedicine (RNM), FMTS, 67000 Strasbourg, France.
Inserm · FRLaboratoire de Biophotonique et Pharmacologie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In humans, aging is associated with endothelial dysfunction and an increased risk of venous thromboembolism. Although intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) at a ratio of 6:1 by old rats improved the endothelial dysfunction in arteries, the impact on veins remains unclear. Eight-month-old male Wistar rats were either untreated or orally administered corn oil, EPA:DHA 1:1, or EPA:DHA 6:1 (500 mg/kg/d) for seven days. Vascular reactivity was studied by myography. In middle-aged femoral artery rings, acetylcholine caused a partial relaxation at low concentrations and a contractile response at high concentrations, whereas in the old femoral vein only a partial relaxation was observed. The EPA:DHA 6:1 treatment blunted the contractile response to acetylcholine in the middle-aged femoral artery and both EPA:DHA 6:1 and 1:1 increased the relaxation to acetylcholine in the old femoral vein. No such effects were observed with corn oil. Both the non-selective cyclooxygenase inhibitor indomethacin and the COX-1 inhibitor SC-560 increased the relaxation to acetylcholine in the middle-aged femoral artery whereas the COX-2 inhibitor NS-398 increased that in the middle-aged femoral vein. In conclusion, our results indicate that aging is associated with an endothelial dysfunction in the femoral artery and vein, which can be improved by EPA:DHA 6:1 treatment-most likely via a cyclooxygenase-dependent mechanism.

Indexed as

Administration, OralAgingAnimalsCyclooxygenase InhibitorsDocosahexaenoic AcidsEicosapentaenoic AcidEndothelium, VascularFemoral ArteryFemoral VeinMaleProstaglandin-Endoperoxide SynthasesRatsRats, WistarVascular DiseasesCyclooxygenase InhibitorsDocosahexaenoic AcidsEicosapentaenoic AcidProstaglandin-Endoperoxide Synthasesagingcyclooxygenasesendothelial dysfunctionomega-3 polyunsaturated fatty acidsvenous thrombosis

Identifiers

PMID32019237
PMCPMC7037507
OpenAlexW3004305508

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.